Signature reversion of three disease‐associated gene signatures prioritizes cancer drug repurposing candidates
Article in FEBS Open Bio (March 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in FEBS Open Bio (March 2024)
Preprint in bioRxiv (March 2023)
Article in Frontiers in Oncology (July 2021)